LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
RVP
Retractable Technologies, Inc.
There isn't enough reported data to score RVP yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
RVP Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Strong |
RVP's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
RVP PE Valuation
RVP has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
RVP Forward outlook
There aren't enough analyst estimates for RVP to show an outlook.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over RVP on earnings quality, reporting a profit while its opponent remains loss making.
RVP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.13 | +$0.15 |
| Q1 2026 | -$0.22 | +$0.54 |
| Q4 2025 | -$0.43 | -$0.03 |
| Q3 2025 | -$0.20 | +$0.34 |
| Q2 2025 | -$0.28 | +$0.33 |
| Q1 2025 | -$0.76 | -$0.50 |
| Q4 2024 | -$0.40 | -$0.16 |
| Q3 2024 | -$0.54 | -$0.17 |
RVP is still losing money, but far less than before: $0.13 per share over the past year, against $0.76 at its worst in early 2025.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over RVP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over RVP on profitability, with a higher operating margin.
RVP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $7.2M | -31% |
| Q1 2026 | $7.2M | -13% |
| Q4 2025 | $9.4M | +4% |
| Q3 2025 | $10.1M | -2.5% |
| Q2 2025 | $10.4M | +73% |
| Q1 2025 | $8.3M | +9.2% |
| Q4 2024 | $9.1M | -36% |
| Q3 2024 | $10.3M | +0.1% |
RVP's revenue has slid since its 2021 peak: $7M last quarter, down 31% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -71% | -22 points |
| Q1 2026 | -86% | -30 points |
| Q4 2025 | -82% | -2.1 points |
| Q3 2025 | -36% | +13 points |
| Q2 2025 | -49% | +47 points |
| Q1 2025 | -56% | -17 points |
| Q4 2024 | -80% | -60 points |
| Q3 2024 | -50% | -41 points |
RVP's operating margin was −71% last quarter, down 22 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over RVP on cash generation, producing positive trailing cash flow while its opponent burns cash.
RVP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.8M | +$2.3M |
| Q1 2026 | -$1.4M | +$187.9K |
| Q4 2025 | -$596.5K | +$806.3K |
| Q3 2025 | -$1.3M | +$5.2M |
| Q2 2025 | -$4.1M | -$1.2M |
| Q1 2025 | -$1.6M | +$686.6K |
| Q4 2024 | -$1.4M | -181% |
| Q3 2024 | -$6.5M | -185% |
RVP has burned cash in most quarters: −$5M over the past year, against −$14M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over RVP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
RVP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | -0.8% | -232K shares |
| 5 years | -13% | -4.4M shares |
| Available history | -8.4% | -2.7M shares |
RVP has 30M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | $4.8M |
| Q3 2022 | — |
| Q2 2022 | $270,453 |
| Q1 2022 | $2.5M |
| Q4 2021 | $2.4M |
| Q3 2021 | $2.7M |
| Q2 2021 | $154,424 |
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
RVP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | -4.8x | Net Cash |
| Q3 2022 | -0.3x | Net Cash |
| Q2 2022 | -0.4x | Net Cash |
| Q1 2022 | -0.7x | Net Cash |
| Q4 2021 | -0.4x | Net Cash |
| Q3 2021 | -0.3x | Net Cash |
| Q2 2021 | -0.3x | Net Cash |
| Q1 2021 | -0.6x | Net Cash |
RVP has more cash than debt.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
RVP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.0 | Neutral |
| Stochastic | 1.7 | Oversold |
RVP's weekly RSI is 33 (neutral) and its Stochastic is 2 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
RVP PE vs Healthcare Sector
| Metric | RVP | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
RVP has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over RVP on trend strength, trading above more of its moving averages.
RVP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.61 | 8.2% below |
| 20 week MA | $0.66 | 15% below |
| 50 week MA | $0.69 | 19% below |
| 100 week MA | $0.73 | 23% below |
| 200 week MA | $0.96 | 42% below |
RVP is in a downtrend: it's below all five of its weekly moving averages, and 42% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over RVP on returns for 2026, with the stronger performance.
RVP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.47 | $11.3 | +669% |
| 2021 | $11.3 | $6.98 | -38% |
| 2022 | $6.98 | $1.74 | -75% |
| 2023 | $1.74 | $1.11 | -36% |
| 2024 | $1.11 | $0.68 | -39% |
| 2025 | $0.68 | $0.83 | +22% |
| 2026 YTD | $0.83 | $0.56 | -33% |
RVP's yearly returns have swung widely, from +669% in 2020 to −75% in 2022. It's down 33% so far in 2026.